#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Osteosarcoma Acute on chronic liver failure Bile acid synthesis disorder Angelman's syndrome Prader-Willi syndrome Astrocytoma Short stature homeobox gene mutation Congenital generalised lipodystrophy Glomerulonephritis chronic Autoimmune demyelinating disease Glycogen storage disease type I Diabetes insipidus Narcolepsy Bulbospinal muscular atrophy congenital Arterial disorder More trials…

    Learn about Rare Diseases

    Marginal zone lymphoma – Basic Information Mucopolysaccharidosis II – Life with Disease Leiomyosarcoma recurrent – Life with Disease Uterine leiomyosarcoma – Diagnostics Angelman’s syndrome – Life with Disease Lysosomal storage disorder Rhabdoid tumour SAPHO syndrome – Trials in Disease Ornithine transcarbamoylase deficiency Mucous membrane pemphigoid – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Concizumab Sasanlimab Mebeverine Hydrochloride RLY-2608 Amphotericine B, Liposome SODIUM BENZOATE Pegargiminase AZD5148 Highly Refined Fish Oil Pertuzumab Elritercept Odronextamab Parsaclisib Hydrochloride Human Fibrinogen Specific Nucleic Acid Sna-Xfsb Zinc Oxide GOLD SODIUM THIOSULFATE Nicotine Cendakimab D-Biotin More therapies…

    Learn about Your Condition

    Impaired gastric emptying Embolism venous Liver disorder Noonan syndrome Familial mediterranean fever Athetosis Bronchiolitis Colorectal cancer stage IV Cervix carcinoma stage IV Thymoma Leber's congenital amaurosis Vasospasm Dengue fever Alveolar rhabdomyosarcoma Huntington's disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer

  • Study of Atezolizumab, Carboplatin, and Etoposide with or Without Tiragolumab for Patients with Untreated Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Atezolizumab
    • Tiragolumab
    Greece Italy Poland

  • Study on Pembrolizumab, Etoposide, and Cisplatin or Carboplatin for First-Line Treatment in Patients with Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Boserolimab
    • Mk-4830
    • Carboplatin
    Austria Hungary Italy Poland Spain

  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Thyroid cancer
    • Transitional cell cancer of the renal pelvis and ureter
    • Malignant melanoma
    Investigated Drugs:
    • Jk08
    • Lenvatinib
    • Pembrolizumab
    Belgium Spain

  • Study of Lurbinectedin Alone or with Irinotecan for Patients with Relapsed Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Small cell lung cancer
    Investigated Drugs:
    • Lurbinectedin
    • Irinotecan
    • Topotecan
    Austria Belgium Bulgaria Denmark France Germany +5

  • Study on the Accuracy of OWL-EVO1 Test for Diagnosing Lung Cancer in Patients Eligible for Screening or with Suspicious CT Findings

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Adenosquamous cell lung cancer recurrent
    • Adenosquamous cell lung cancer stage 0
    • Adenosquamous cell lung cancer stage I
    Investigated Drugs:
    • D5-Ethyl-Beta-D-Glucuronide
    Czechia Hungary

  • Study of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuroendocrine tumour of the lung
    Investigated Drugs:
    • Satoreotide Trizoxetan Gallium Ga-68
    Denmark
Previous Page
1 … 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!